• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Antiangiogenic Effects of E1E4^+ and E1^-E4^-Adenoviral Vectorsand Its Possible Mechanism

Research Project

Project/Area Number 14571685
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Ophthalmology
Research InstitutionSaitama Medical School

Principal Investigator

MORI Keisuke  Saitama Medical School, Ophthalmology, Associate Professor, 医学部, 助教授 (90251090)

Co-Investigator(Kenkyū-buntansha) YONEYA Shin  Saitama Medical School, Ophthalmology, Professor, 医学部, 教授 (40143234)
SHIBUYA Masayuki  Saitama Medical School, Ophthalmology, Research Associate, 医学部, 助手 (80337576)
MORI Keisuke  Saitama Medical School, Ophthalmology, Associate Professor (90251090)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥2,100,000 (Direct Cost: ¥2,100,000)
Keywordsadenoviral vector / angiogenesis / microarray / neuroprotection / 血管新生抑制作用 / early region 4
Research Abstract

The purpose of this study is to identify the genes which are up-or down-regulated by intraocular injection of both El, E3 deleted and El, E3, E4 deleted adenoviral vectors. Adenoviral vectors are intravitreously injected to mice eyes and then mRNA expression was screened by cDNA or oligonucleotide microarray. Animals are divided into 2 categories ; one is normal untreated mice, and the other is mice with oxygen-induced ischemic retinopathy. For the mice model of ischemic retinopathy mice were housed in 75% oxygen from P7 to P12. Viral vectors were injected Pl0 and eyes were enucleated P13.
In normal eyes with GVl0 injection 580 genes were up or down regulated, when compared to eyes without vector injection among 12,422 probesets and ESTs. Also, in normal eyes with GV11 injection 660 genes were up or down regulated, when compared to eyes without vector injection. These were also tested in mice eyes with ischemic retinopathy and found totally 60 genes were up-or down-regulated. Among these genes MHC class I antigen is one of the aniogenesis related gene. There were some more candidate genes to screen out their function.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] Takita H, et al.: "Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor."Invest Ophthalmol Vis Sci. 44. 4497-4504 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imai D, et al.: "Intraocular gene transfer of pigment epithelium-derived factor rescues photoreceptors from light-induced cell death."Journal of Cellular Physiology. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takita H, et al.: "Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor."Invest Ophthalmol Vis Sci. 44. 4497-4504 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imai D, et al.: "Intraocular gene transfer of pigment epithelium-derived factor rescues photoreceptors from light-induced cell death."J Cell Physiol. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takita H, et al.: "Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor."Invest Ophthalmol Vis Sci. 44. 4497-4504 (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi